metastatic breast cancer
Showing NaN - NaN of 51
Metastatic Breast Cancer Trial in Boston (Palliative and Oncology Care, Standard Oncology Care)
Active, not recruiting
- Metastatic Breast Cancer
- Palliative and Oncology Care
- Standard Oncology Care
-
Boston, MassachusettsMassachusetts General Hospital
Sep 15, 2021
Metastatic Breast Cancer Trial in Boston (Pembrolizumab, Palliative radiotherapy)
Terminated
- Metastatic Breast Cancer
- Pembrolizumab
- Palliative radiotherapy
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 31, 2021
Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Boston (Ruxolitinib, Paclitaxel)
Completed
- Recurrent Breast Cancer
- Metastatic Breast Cancer
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 26, 2021
Castration-resistant Prostate Cancer, Metastatic Breast Cancer, Uterine Leiomyoma Trial in Worldwide (LFA102)
Completed
- Castration-resistant Prostate Cancer
- +2 more
-
Boston, Massachusetts
- +8 more
Dec 16, 2020
Metastatic Breast Cancer Trial in Worldwide (Eribulin Mesylate, Capecitabine)
Completed
- Metastatic Breast Cancer
- Eribulin Mesylate
- Capecitabine
-
Anaheim, California
- +168 more
May 28, 2020
Metastatic Breast Cancer Trial in Belgium, United States (LY3295668 Erbumine, Endocrine therapy, Midazolam)
Completed
- Metastatic Breast Cancer
- LY3295668 Erbumine
- +2 more
-
Duarte, California
- +6 more
May 29, 2020
Metastatic Breast Cancer Trial in Worldwide (Pertuzumab, Placebo, Trastuzumab)
Breast Cancer, Metastatic Breast Cancer Trial in Boston (trastuzumab, vinorelbine)
Terminated
- Breast Cancer
- Metastatic Breast Cancer
-
Boston, Massachusetts
- +2 more
Jan 16, 2019
Metastatic Breast Cancer, Breast Cancer, Progressive Breast Cancer Trial in Boston (carboplatin, bevacizumab, herceptin)
Completed
- Metastatic Breast Cancer
- +2 more
- carboplatin
- +2 more
-
Boston, Massachusetts
- +2 more
Dec 10, 2018
HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pertuzumab, Trastuzumab, eribulin)
Terminated
- HER2-positive Breast Cancer
- Metastatic Breast Cancer
- Pertuzumab
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 9, 2018
Metastatic Breast Cancer Trial in Boston (Verteporfin, Continuous Low-Irradiance Photodynamic Therapy (CLIPT))
Unknown status
- Metastatic Breast Cancer
- Verteporfin
- Continuous Low-Irradiance Photodynamic Therapy (CLIPT)
-
Boston, Massachusetts
- +1 more
Jul 18, 2018
Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +
Completed
- Breast Cancer
- +3 more
- Abraxane alone
- Abraxane + Tigatuzumab
-
Birmingham, Alabama
- +9 more
Oct 24, 2017
Metastatic Breast Cancer Trial in United States (GTx-024 9mg)
Completed
- Metastatic Breast Cancer
- GTx-024 9mg
-
Miami, Florida
- +3 more
Mar 14, 2017
Circulating Tumor Cells From Metastatic Breast Cancer Using
Completed
- Metastatic Breast Cancer
- Blood collection
-
Phoenix, Arizona
- +19 more
Mar 7, 2017
Metastatic Breast Cancer Trial in United States (paclitaxel, pertuzumab [Perjeta], trastuzumab emtansine [Kadcyla])
Metastatic Breast Cancer Trial in United States (Letrozole, Trastuzumab)
Completed
- Metastatic Breast Cancer
-
Washington, District of Columbia
- +3 more
Sep 12, 2014
Metastatic Breast Cancer Trial in Boston, New York, Essen (tivozanib (AV-951) + paclitaxel)
Completed
- Metastatic Breast Cancer
- tivozanib (AV-951) + paclitaxel
-
Boston, Massachusetts
- +2 more
Jun 27, 2012